Early research (Phase 1)Study completedNCT00258271
What this trial is testing
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
Who this might be right for
Leukemia
University of Rochester 18